Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09CIC
|
|||
Drug Name |
Tricyclic heterocycle derivative 4
|
|||
Synonyms |
PMID26077642-Compound-Figure3D
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
PRESIDENT AND FELLOWS OF HARVARD COLLEGE FINLEY, Daniel KING, Randall, W. LEE, Byung-Hoon LEE, Min, Jae GAHMAN, Timothy, C
|
|||
Structure |
Download2D MOL |
|||
Formula |
C14H17N3S
|
|||
Canonical SMILES |
CN(C1CC1)C2=C3C4=C(CCCC4)SC3=NC=N2
|
|||
InChI |
1S/C14H17N3S/c1-17(9-6-7-9)13-12-10-4-2-3-5-11(10)18-14(12)16-8-15-13/h8-9H,2-7H2,1H3
|
|||
InChIKey |
PGGINYVNLNKQRD-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Ubiquitin carboxyl-terminal hydrolase 14 (USP14) | Target Info | Inhibitor | [1] |
Target's Patent Info | Ubiquitin carboxyl-terminal hydrolase 14 (USP14) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Deubiquitinases (DUBs) and DUB inhibitors: a patent review.Expert Opin Ther Pat. 2015;25(10):1191-1208. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.